Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco L. Davila"'
Autor:
Claudio Anasetti, Justin C. Boucher, Brian C. Betts, Marco L. Davila, Kelly Walton, Gongbo Li, Tayyebb Ghafoor, Elizabeth M. Sagatys, Nhan Tu, Joseph Pidala, Martin Felices, Jeffrey S. Miller, Jordan Reff, Bishwas Shrestha, Bruce R. Blazar
Publikováno v:
J Clin Invest
Graft-versus-host disease (GVHD) remains an important cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). For decades, GVHD prophylaxis has included calcineurin inhibitors, despite their incomplete efficac
Publikováno v:
J Clin Invest
Chimeric antigen receptor (CAR) T cell therapy has shown considerable promise for hematologic malignancies, leading to the US Food and Drug Administration approval of two CAR T cell-based therapies for the treatment of B cell acute lymphoblastic leuk
Autor:
Brigett Brandjes, Marco L. Davila
Publikováno v:
J Clin Invest
With the approval of CD19-targeted chimeric antigen receptor (CAR) T cells for the treatment of B cell malignancies, clinicians have gained valuable insights into the power and challenges of cellular therapies. In this issue of the JCI, Maluski et al